Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

microRNA

  • You have access
    MiR-221 Is Specifically Elevated in PC3 Cells and its Deletion Reduces Adhesion, Motility and Growth
    D. ALWYN DART, SARAH KOUSHYAR, BEN E. LANNING and WENGUO JIANG
    Anticancer Research October 2019, 39 (10) 5311-5327; DOI: https://doi.org/10.21873/anticanres.13724
  • You have access
    High miR-3687 Expression Affects Migratory and Invasive Ability of Oesophageal Carcinoma
    KOTARO HAGIO, SHINJI FURUYA, JIRO NAKAMURA, SUGURU MARUYAMA, KENSUKE SHIRAISHI, HIROKI SHIMIZU, HIDENORI AKAIKE, NAOHIRO HOSOMURA, YOSHIHIKO KAWAGUCHI, HIDETAKE AMEMIYA, HIROMICHI KAWAIDA, MAKOTO SUDO, SHINGO INOUE, HIROSHI KONO and DAISUKE ICHIKAWA
    Anticancer Research February 2019, 39 (2) 557-565; DOI: https://doi.org/10.21873/anticanres.13148
  • You have access
    MicroRNA Expression in the Progression and Aggressiveness of Papillary Thyroid Carcinoma
    AGNIESZKA ZEMBSKA, ALEKSANDRA JAWIARCZYK-PRZYBYƁOWSKA, BEATA WOJTCZAK and MAREK BOLANOWSKI
    Anticancer Research January 2019, 39 (1) 33-40; DOI: https://doi.org/10.21873/anticanres.13077
  • You have access
    Targeted Therapies for Pancreatic Cancer and Hurdles Ahead
    MINELA ASLAN, REZA SHAHBAZI, KEZBAN ULUBAYRAM and BULENT OZPOLAT
    Anticancer Research December 2018, 38 (12) 6591-6606; DOI: https://doi.org/10.21873/anticanres.13026
  • You have access
    Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion
    HIROYUKI TAMIYA, AKIHISA MITANI, AKIRA SAITO, TARO ISHIMORI, MINAKO SAITO, HIDEAKI ISAGO, TAISUKE JO, YASUHIRO YAMAUCHI, GOH TANAKA and TAKAHIDE NAGASE
    Anticancer Research December 2018, 38 (12) 6707-6714; DOI: https://doi.org/10.21873/anticanres.13039
  • You have access
    Identification of a Novel MicroRNA Panel Associated with Metastasis Following Radical Prostatectomy for Prostate Cancer
    ROBERT K. NAM, CHRISTOPHER J.D. WALLIS, YUTAKA AMEMIYA, TANIA BENATAR and ARUN SETH
    Anticancer Research September 2018, 38 (9) 5027-5034; DOI: https://doi.org/10.21873/anticanres.12821
  • You have access
    Potential Oncogenic Role and Prognostic Implication of MicroRNA-155-5p in Oral Squamous Cell Carcinoma
    HYOJIN KIM, JEONG MI YANG, SOON-HYUN AHN, WOO-JIN JEONG, JIN-HAENG CHUNG and JIN HO PAIK
    Anticancer Research September 2018, 38 (9) 5193-5200; DOI: https://doi.org/10.21873/anticanres.12842
  • You have access
    Tumor Expression of miR-10b, miR-21, miR-143 and miR-145 Is Related to Clinicopathological Features of Gastric Cancer in a Central European Population
    RADKA OBERMANNOVA, MARTINA REDOVA-LOJOVA, PETRA VYCHYTILOVA-FALTEJSKOVA, PETER GRELL, WILLIAM C. CHO, MILANA SACHLOVA, MAREK SVOBODA, ROSTISLAV VYZULA and ONDREJ SLABY
    Anticancer Research June 2018, 38 (6) 3719-3724; DOI: https://doi.org/10.21873/anticanres.12651
  • You have access
    Candidate MicroRNA Biomarkers of Therapeutic Response to Sunitinib in Metastatic Renal Cell Carcinoma: A Validation Study in Patients with Extremely Good and Poor Response
    JULIA KOVACOVA, JAROSLAV JURACEK, ALEXANDR POPRACH, TOMAS BUCHLER, JINDRICH KOPECKY, ONDREJ FIALA, MAREK SVOBODA and ONDREJ SLABY
    Anticancer Research May 2018, 38 (5) 2961-2965;
  • You have access
    Molecular Sequence of Events and Signaling Pathways in Cerebral Metastases
    JARED B. COOPER, JENNIFER S. RONECKER, MICHAEL E. TOBIAS, AVINASH L. MOHAN, VIRANY HILLARD, RAJ MURALI, CHIRAG D. GANDHI, MEIC H. SCHMIDT and MEENA JHANWAR-UNIYAL
    Anticancer Research April 2018, 38 (4) 1859-1877;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire